To construct point mutations in V. cholerae, double homologous recombination using the sacB-lethality counterselection method was used (2) . PCR SOE was used to amplify a 1.2 kB fragment with ~0.5 kB of homologous sequence flanking the point mutation. The flanking primers used for the SOE reaction were #35 and #36, while the internal primers were #21 and #22 (W192A), #23 and #24 (C140A), and #32 and #33 (R182Q/K183N). The rtxA deletion mutant was constructed by performing PCR SOE to generate an in-frame deletion fragment that removes amino acids 14-4557 of RTX. The flanking primers were #37 and #38, and the internal SOE primers were #39 and #40. PCR fragments were ligated into the sucrose-based counter selectable plasmid pGP704-Sac28 using the NcoI/XbaI sites (3) . Allelic exchange plasmids were transformed into E. coli SM10λpir and mated into the recipient V. cholerae strain.
Consistent with previous studies of V. cholerae RTX function, the V. cholerae N19691 strain referred to as wildtype contains an in-frame deletion in hapA to reduce heterologous proteolysis of RTX (4) (5) (6) . Sucrose-based counter selection was done essentially as described (6) , and mutations were confirmed by PCR and genomic DNA sequencing.
In vitro CPD cleavage assay. Autocleavage of N-terminally His 6 -tagged CPD variants (corresponding to RTX amino acids 3391-3650) was performed in 75 µL reaction volumes containing 1 µM CPD enzyme in cleavage assay buffer (60 mM NaCl, 20 mM Tris pH 7.5, 250 mM sucrose). Inositol hexakisphosphate (InsP 6 , Calbiochem), inositol (1, 3, 4, 5, 6) pentakisphosphate (Ins(1,3,4,5,6)P 5 , Calbiochem), or inositol (1,4,5,6) tetrakisphosphate (Ins(1,4,5,6)P 4 , Sigma) were added to cleavage reactions at a 1:100 dilution to give the indicated concentrations. Guanosine 5′-[γ-thio]triphosphate (GTPγS, Sigma) was added at a 1:10 dilution.
Cleavage reactions were incubated at 37ºC for 2 h, after which autocleavage was stopped by the addition of SDS-PAGE loading buffer. Samples were boiled for 3 min at 95ºC and resolved by SDS-PAGE on 15% gels. Cleavage reactions were visualized by Coomassie staining and quantified using the program ImageJ (http://rsb.info.nih.gov/ij/). The amount of autocleaved protein relative to the total protein amount was plotted versus concentration of ligand. The AC 50 (the concentration of ligand that produced half-maximal cleavage) was determined from these plots using the Michaelis-Menten function on KaleidaGraph.
Protein expression and purification. For purification of N-terminally His 6 -tagged CPD variants used in enzyme assays, overnight cultures of the appropriate strain were diluted 1:500 in 500 mL 2YT media and grown shaking at 37ºC. When an OD 600 of 0.6 was reached, IPTG was added to 350 µM, and cultures were grown for 4 hr at 30ºC. Cultures were pelleted, resuspended in 25 mL lysis buffer [500 mM NaCl, 50 mM Tris-HCl, pH 7.5, 15 mM imidazole, 10% glycerol] and flash frozen in liquid nitrogen. Lysates were thawed, then lysed by sonication and cleared by centrifugation at 15,000 x g for 30 minutes. His 6 -tagged CPD (amino acids 3391-3650) was affinity purified by incubating the lysates in batch with 0.5 mL Ni-NTA Agarose beads (Qiagen) with shaking for 1 hr at 4ºC. The binding reaction was pelleted at 1,500 x g, the supernatant was set aside, and the pelleted Ni-NTA agarose beads were washed 3 x with lysis buffer. His 6 -tagged CPD was eluted from the beads by the addition of 250 µL elution buffer [500 mM NaCl, 50 mM Tris-HCl, pH 7.5, 175 mM imidazole, 10% glycerol]. The affinity pulldown was repeated on the reserved supernatant to maximally recover His 6 -tagged CPD proteins.
Purified His 6 -tagged CPD proteins were stored at -20ºC in elution buffer.
Wildtype and mutant cleaved CPD (amino acids 3442-3650) containing a C-terminal BirA biotinylation sequence (LHHILDAQKMVWNHR) and a His 6 -tag were affinity purified as described above. The purified samples were buffer exchanged into gel filtration buffer [250 mM NaCl, 10 mM Tris-HCl pH 7.5] and further purified by gel filtration chromatography using an S200 16/60 Sephacryl column (GE Healthcare). Protein fractions were pooled and concentrated in a low salt buffer [100 mM NaCl, 10 mM Tris-HCl pH 7.5] to 100 µM. Protein concentration was determined by Bradford assay. Cleaved CPD variants were biotinylated in vitro with GSTBirA enzyme (7) and purified on a Superdex 200 10/30 column (GE Healthcare) equilibrated in 10 mM Tris-HCl, pH 7.4, 150 mM NaCl to remove excess biotin for use in SPR assays.
Purification of CPD for crystallization. For purification of cleaved CPD used for crystallization studies, the affinity purification procedure was performed as described above with the following modifications. His 6 -tagged CPD was purified from 3 L culture of BL21(DE3) harboring pET28a-CPDstop, and His 6 -tagged CPD was eluted from 1.5 mL NiNTA agarose beads in a final volume of 1 mL elution buffer. The affinity purified His 6 -tagged CPD was autocleaved by adding 9 mL CPD cleavage buffer containing 100 μM InsP 6 and incubating the cleavage reaction at 37ºC for 1 hr. The cleaved CPD was buffer exchanged into lysis buffer using a 10 kDa Centricon concentrator (Millipore), and incubated with 500 µL Ni-NTA agarose beads at 4˚C for 1 hr to pull-down both uncleaved His 6 -tagged CPD and the N-terminal His 6 -tagged fragment liberated upon auto-cleavage. Binding reactions were pelleted at 1,500 g, and the supernatant containing untagged cleaved CPD was buffer exchanged into gel filtration buffer [250 mM NaCl, 10 mM Tris pH 7.5]. Untagged cleaved CPD (amino acids 3442-3650) was further purified by gel filtration chromatography using an S200 16/60 Sephacryl column (GE Healthcare). The protein was concentrated in gel filtration buffer to a concentration of 30 mg/mL. Protein concentration was determined by measuring the absorbance at 280 nm. Crystallization and data collection. For crystallization trials, native and seleno-methionine substituted N-terminal cleaved RTX CPD was concentrated to 1 mM (~30 mg/mL) in 10 mM Tris pH 7.5 and 250 mM NaCl. A twofold excess (2 mM) of InsP 6 (Calbiochem) was added before crystallization. Small needle-like crystals were initially obtained using the sitting-drop vapor diffusion method from the Synergy 64 crystallization screen (Emerald Biosystems) in 30% PEG 3350, 30% isopropanol, Tris-HCl pH 8.5. We were unable to obtain crystals of the RTX CPD in the absence of InsP 6 in any conditions. Diffraction-quality crystals were ultimately grown in an equal volume of 100 mM Tris-HCl pH 8.5, 30% PEG 3350, and 15% MPD at 22ºC.
Se-Met crystals were grown by microseeding with native crystals. Crystals were flash frozen in liquid nitrogen using the mother liquor as a cryoprotectant, and data was collected under cryocooled conditions at 100 K. A 2.1Å native data set was collected at beamline 11-1 at the Stanford Synchotron Radiation Laboratory and a 2.8Å Se-Met data set was collected at beamline 8.2.1 at the Advanced Light Source (UC-Berkeley). Diffraction data were processed with HKL2000 (8) . Data processing statistics are listed in Table S1 .
Structure determination and refinement. Initial phases were obtained from a selenomethionine data set collected at the peak absorption wavelength of 0.9798 Å by single wavelength anomalous dispersion (SAD). Eight selenium heavy atom positions were obtained using SHELX (9) , corresponding to two sites in each of the four molecules in the asymmetric unit. Initial phases were calculated using SHARP (10) (17) indicates 88.5% of residues reside in the most favorable regions, while 11.5% reside in the additionally allowed regions. Refinement statistics can be found in table S1. Hydrogen bond contacts were calculated using Contact from the CCP4 program package (18) and buried surface area was calculated using CNS. Structural figures were prepared using PyMol (19) , and electrostatic surface potential was calculated with APBS (20) contoured at +/-5 kT/e. Structural comparisons were made using the DALI server (21) .
The final model consists of two RTX CPD molecules in the asymmetric unit, with chain A consisting of amino acids 1-205 and chain B consisting of residues 5-205. Density for residues 1-4 in chain A is seen extending away from the active site to make crystal contacts with another CPD molecule in the lattice, not with its cognate polypeptide chain, hence Ile5 is cited as the first residue in the model. Chain B is used for all figures in the paper. One InsP 6 molecule is seen bound to each CPD molecule, and a single Na+ ion is modeled into the structure of each CPD molecule coordinated by the C1 and C2 phosphates and main chain carbonyl of Glu27.
Surface Plasmon Resonance (SPR) Measurements. SPR measurements were performed at 25ºC using a Biacore T100 instrument equilibrated in 10 mM Tris-HCl, 150 mM NaCl, pH 7.4 (TBS). After pretreatment of the streptavidin-coupled (SA) chip, ~4000 RU biotinylated CPD was immobilized on each channel leaving one flow channel as a blank (streptavidin alone) control. The chip was then treated with 1 μM biotin to occupy remaining SA binding sites.
Preliminary experiments indicated that catalytically active CPD could cleave itself off the chip while exposed to InsP 6 , so it was necessary to pre-treat the chip with a TBS solution containing 1 mM InsP 6 and 100 μM N-ethylmaleimide to neutralize protease activity. Both iodoacetic acidneutralized CPD and a catalytic cysteine-to-alanine (C140A) mutant had similar InsP 6 binding affinities (Fig. 4 and data not shown), indicating that coupling of a maleimide to the catalytic cysteine did not appreciably affect InsP 6 binding. For binding measurements, InsP 6 was diluted in TBS and three consecutive dilution series (0.01-125 μM) were flowed over the chip at 50 μL/min (150 μL/180 s injection, 500 s wash). Binding affinities were calculated using the Biacore T100 Evaluation software.
Fluorogenic substrate cleavage assay. 1.1 µM of N-terminally His 6 -tagged full-length CPD (corresponding to RTX amino acids 3391-3650) was mixed with 1.1 x the indicated concentration of Z-GGL-AMC (BioMol) in cleavage assay buffer (60 mM NaCl, 20 mM Tris pH 7.5, 250 mM sucrose). 90 µL of the enzyme-substrate mixture was added to flat bottom 96 well plates (black). 10 µL of InsP 6 (10-fold stock of the indicated concentration, Calbiochem) was added to the enzyme-substrate mixture to initiate the substrate cleavage reaction. Hydrolysis of Z-GGL-AMC by recombinant CPD was followed using a Molecular Devices fmax plate reader at 37ºC. Cleavage of the substrate as a function of time was followed by monitoring the emission at 460 nm following excitation at 380 nm. The initial velocity was determined from the linear portion of progress curve and plotted against InsP 6 concentration (to generate the InsP 6 activation curve) and against Z-GGL-AMC concentration (to generate the substrate saturation curve). The Michaelis-Menten function on KaleidaGraph (KaleidaGraph) was used to determine the K a (InsP 6 concentration at which V o cleavage rate is half-maximal at a given Z-GGL-AMC concentration) and K m (substrate concentration at which V o cleavage rate is half-maximal at a given InsP 6 concentration). It should be noted that no substrate cleavage was observed in the absence of InsP 6 , emphasizing the strict dependence for CPD protease activity on InsP 6 . A high concentration of CPD was used in this assay given that low levels of substrate turnover was observed at lower concentrations of CPD, a finding that likely reflects low catalytic efficiency for the fluorogenic peptide substrate. 
Western blot analysis of RTX toxin. For detection of RTX in supernatant fractions, overnight
V. cholerae strains grown at 37ºC in LB shaking were diluted 1:100 into 3.5 mL LB media.
Diluted cultures were grown to mid-log phase (OD 600 ~0.5, ~2.25 hr growth) then pelleted at 5,000 x g for 5 min. The resulting supernatant was precipitated in 10% tricholoroacetic acid (TCA, final concentration) and incubated for 1 hr on ice. Precipitates were pelleted at 10,000 x g for 10 min, washed once with 1 mL cold acetone, and the resulting pellet was re-suspended in 125 μL of LDS (Invitrogen) loading buffer containing 0.01 N NaOH and 5 mM DTT. Samples were heated to 70ºC for 10 min then loaded onto a 3-8% Tris-Acetate pre-cast gel (Invitrogen). A high degree of conservation is observed among basic cage residues (boxed and labeled in purple) and ®-hairpin residues (boxed and labeled in black), suggesting that the mechanism of InsP 6 -activation is conserved. The numbering of V. cholerae CPD InsP 6 binding residues and ®-flap residues is given relative to the core protease domain and starts after the indicated cleavage site for the V. cholerae CPD. The sequence alignment was performed using ClustalW; the figure was generated using Boxshade running on the San Diego Supercomputing Server. Proteins are rainbow colored starting with the N-terminus in blue and ending with the C-terminus in red, and catalytic Cys and His residues are labeled for orientation. Structural alignments were calculated using the DALI server (21) (www2.ebi.ac.uk/dali). Gingipain R had a DALI Z-score of 6.0, with an rmsd of 3.8Å and 9% sequence identity (118 out of 432 residues aligned), and 
